Skip to main content
Top
Published in:

Open Access 22-05-2025 | Cervical Cancer | Case Report

HPV-associated squamous cell carcinoma and adenocarcinoma in distinct cervical sites: a case report

Authors: Huihui Chen, Qingyi Wang, Min Kang, Wei Huang, Hao Zhang, Jiaxin Li, Donghan Xu, Lin Zhao, Bowen Wu, Xin Lin, Liqi Li, Yuhong Zheng, Yihao Niu, Jiaqi Zhou, Donghui Huang, Peiyu Yan

Published in: BMC Infectious Diseases | Issue 1/2025

Login to get access

Abstract

Background

The synchronous occurrence of adenocarcinoma and squamous cell carcinoma in distinct cervical regions is exceptionally rare. This report highlights a case of HPV-associated adenocarcinoma and squamous cell carcinoma at distinct sites in a patient with primary stage IA1 cervical cancer.

Case presentation

A 54-year-old female tested HPV type 18 positive in a routine physical exam. Cervical Liquid - based Cytology Test (LCT) showed Atypical Squamous Cells of Undetermined Significance (ASCUS). Colposcopy-directed biopsies revealed moderately differentiated squamous cell carcinoma at multiple sites (3, 6, 9, 12 o’clock positions and the ECC), with a clinical diagnosis of stage IA1. Preoperative abdominal MRI (including contrast enhancement) showed no lymph node enlargement, and urinary CT urography was normal. Squamous cell carcinoma antigen levels were within the normal range.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
HPV-associated squamous cell carcinoma and adenocarcinoma in distinct cervical sites: a case report
Authors
Huihui Chen
Qingyi Wang
Min Kang
Wei Huang
Hao Zhang
Jiaxin Li
Donghan Xu
Lin Zhao
Bowen Wu
Xin Lin
Liqi Li
Yuhong Zheng
Yihao Niu
Jiaqi Zhou
Donghui Huang
Peiyu Yan
Publication date
22-05-2025
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2025
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-025-11114-y

ASCO 2025 Annual Meeting

Keep up to date with the latest in oncology research with our ASCO 2025 hub page, featuring official videos, breaking news, and more.

Read more

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more